medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (4)

Primary cutaneous melanoma: An update depicting the importance in early detection and treatment by the dermatologist (Part two)

Asz SD, Aguilar DA, Fonte ÁV, Domínguez CJ

Language: Spanish
References: 20
Page: 258-261
PDF size: 225.00 Kb.


ABSTRACT

Melanoma is a malignancy of the pigment-producing cells (melanocytes) located predominantly in the skin. It accounts for only 4% of all skin cancers; however, it causes the greatest number of skin cancer–related deaths worldwide. Tumor thickness in millimeters (Breslow level), the presence of ulceration, and positive sentinel node detected by biopsy are the three most important prognostic factors. The role of the dermatologist in the early detection of primary cutaneous melanoma is the best tool in reducing morbimortality.


REFERENCES

  1. Swetter S. Malignant melanoma. http://www.eMedicine.com, Enero de 2008.

  2. Sober A, Chuang T, Duvic M, Farmer ER, Grichnik JM, Halpern AC, et al. “Guidelines of care for primary cutaneous melanoma”. J Am Acad Dermatol 2001; 45: 579-586.

  3. Urist M, Soong S. “Melanoma and Cutaneous Malignancies”. [in:] Sabiston Textbook of Surgery, 18th ed. Philadelphia, Saunders 2008, 241-256.

  4. Sampsel JW, Barbera-Guillem E. “Management of Cutaneous Melanoma”. N Engl J Med 2004; 351(26): 2770-2771.

  5. Miller AJ, “Mihm MC Jr. Melanoma”. N Engl J Med 2006 6; 355(1): 51-65.

  6. Swetter S. “Dermatological perspectives of malignant melanoma”. Surg Clin North Am 2003; 83(1): 77-95.

  7. Oliveria SA, Sachs D, Belasco KT, Halpern AC. “Adoption of new technologies for early detection of melanoma in dermatologic practice”. J Am Acad Dermatol 20; 49(5): 955-959.

  8. Brown CK, Kirkwood JM. “Medical management of melanoma“. Surg Clin North Am 2003; 83(2): 283-322.

  9. Malvehy J, Puig S, Braun R, et al. Manual de dermatoscopía. BCN Art Directe S.L. 1a edición. España 2006: 55-67.

  10. Bong JL, Herd RM, Hunter JA. “Incisional biopsy and melanoma prognosis”. J Am Acad Dermatol 2002; 46(5): 690-694.

  11. Reeves M, Coit D. “Melanoma. A multidisciplinary approach for the general surgeon”. Surg Clin North Am 2000; 80(2): 581-601.

  12. Krown SE, Chapman PB. “Defining adequate surgery for primary melanoma”. N Engl J Med 2004 19; 350(8): 823-825.

  13. Hurt MA. “Excision margins in high-risk malignant melanoma”. N Engl J Med 2004; 350(22): 2305-2306.

  14. Thompson JF. “Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination”. Surg Oncol Clin N Am 2006; 15(2): 301-318.

  15. Johnson TM, Sondak VK, Bichakjian CK, Sabel MS. “The role of sentinel lymph node biopsy for melanoma: evidence assessment”. J Am Acad Dermatol 2006; 54(1): 19-27.

  16. McPherson M, Elwood M, English D, Baade PD, Youl PH, Aitken JF. “Presentation and detection of invasive melanoma in a high-risk population”. J Am Acad Dermatol 2006; 54(5): 783-792.

  17. Essner R. “Surgical treatment of malignant melanoma”. Surg Clin North Am 2003; 83(1): 109-156.

  18. Emery RE, Stevens JS, Nance RW, Corless CL, Vetto JT. “Sentinel node staging of primary melanoma by the ‘10% rule’: pathology and clinical outcomes”. Am J Surg 2007; 193(5): 618-622.

  19. Zettersten E, Shaikh L, Ramirez R, Kashani-Sabet M. “Prognostic factors in primary cutaneous melanoma”. Surg Clin North Am 2003; 83(1): 61-75.

  20. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. “Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions”. J Am Acad Dermatol 2007; 57(4): 555-557.




2020     |     www.medigraphic.com